EvaluatePharma^® – helping you to find value in the pharmaceuticals and biotechnology sector.

EvaluatePharma^® provides comprehensive coverage of more than 900 companies and over 13,500 products from early stage R&D through to Marketed and beyond, tracking the past and future performance of the pharma and biotech business sectors.

Historic sales (since 1986), consensus forecasts to 2012, peak sales and detailed company financials, including earnings estimates to 2012, are delivered via an exceptionally user-friendly web interface.

Consensus forecasts are compiled from the reports of leading securities analysts, and include sales forecasts to 2012, forecast range (min and max; median), and analyst forecast dates, updated on a monthly basis.

Company-reported quarterly sales are uploaded as they become available, while news items are classified and added daily.

It’s easy to customize any report to meet your market analysis needs.

• Perform instant company merger analysis
• Benchmark against industry peer groups and their products in seconds
• Identify key industry growth drivers at the glance of a chart
• Compare your forecasts against the industry’s consensus forecasts effortlessly
• Create comprehensive macro level Company Rankings or Therapy Rankings Reports by historic sales or forecasts out to 2012
• Gain insights into all sales at risk from patent expiries
• Plus volumes of other industry analysis

EvaluatePharma^® helps you find the answers you need!

Click here to view Sample Company Reports from EvaluatePharma.